The European technology sector is showing promise, with the STOXX Europe 600 Index rebounding in March 2025, driven by expected government investments despite concerns about U.S. tariffs. Companies like Elicera Therapeutics and XTPL lead the growth in this sector, with XTPL achieving

Rising colorectal cancer rates among individuals under 50 highlight an urgent medical issue, with it being the leading cancer killer for young men and second for young women. Despite its increase, experts suggest colorectal cancer is highly preventable concerning early detection and

QCI experienced significant financial growth in 2024, boosting cash reserves by $187.9 million through common stock ventures and convertible promissory notes. A strategic partnership with NASA has propelled advancements in quantum remote sensing and phase unwrapping, promising transformative changes in technology. The

Artificial intelligence (AI) and quantum computing are merging to tackle the simulation of many-body open quantum systems (OQSs), vital for physics, chemistry, biology, and materials science. Simulating these systems traditionally faced the “exponential wall problem,” where computational demands grew exponentially with size

Emma Wen, a resilient cancer survivor, is determined to inspire others battling illnesses through her achievements and ambitions. As a senior at Great Neck North High School, Emma excels in academic and altruistic pursuits, including volunteering as an EMT and ballet dancing.

Technology giants like Apple, Microsoft, Amazon, and Alphabet dominate the trillion-dollar club, alongside Nvidia and Meta Platforms, driven by AI demand. TSMC and Broadcom, significant players in chipmaking and network solutions, recently fell below the trillion-dollar market cap but are poised for

The study highlights the critical role of N6-methyladenosine (m6A), an RNA modification, in prostate cancer progression and treatment potential. Researchers identified over 32,000 m6A sites across 9,571 genes in prostate tumors, affecting oncogenes like MYC and AR, but sparing tumor suppressors such

PsiQuantum is seeking $750 million in funding, aiming to boost its valuation to $6 billion, driven by BlackRock’s investment. Rather than using exotic materials, PsiQuantum utilizes traditional semiconductor manufacturing and photonics technology. The company collaborates with GlobalFoundries in New York to produce

PsiQuantum is a pioneering quantum computing startup based in Silicon Valley, aiming to transform the computing landscape. The company has secured $750 million in funding, led by BlackRock, reaching a $6 billion pre-money valuation. PsiQuantum’s mission focuses on building large-scale quantum computers